drugset / Trial / NCT00000605

Estrogen and Graft Atherosclerosis Research Trial (EAGER)

NCT00000605

RandomizedDouble-blindPrevention

Summary

To determine if postmenopausal hormone replacement therapy in women following coronary bypass surgery would reduce the occurrence of graft occlusion and delay the development of graft atherosclerosis.

Timeline

Start
1996-08
Primary completion
Completion
2002-07

Drugs

EvaluationDrugModalityDoseRoute
Subject conjugated estrogens Other / unclassified
Subject medroxyprogesterone acetate Other / unclassified